IP Library Granted Patent US 8,148,124
Granted Patent B2
US 8,148,124 · App. 11/736,504 · Granted Apr 3, 2012

Regulation of gene expression by protein methylation

Assignees: The Regents of the University of California; University of Southern California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,148,124
App. No.
11/736,504
Granted
Apr 3, 2012
Kind
B2
Abstract

The invention relates to the cDNA and deduced amino acid sequence of the Coactivator Associated arginine (R) Methyltransferase protein, CARM1. A method is described for the use CARM1 to regulate gene expression in vivo. CARM1 has also been used to methylate arginine residues of histones, synthetic peptides, and other proteins. A method to use CARM1 to screen for drugs that inhibit its methyltransferase activity is also described, as is a method to screen for drugs that modulate CARM1's interactions with other proteins.

Claims (13)

1. An isolated or recombinant polypeptide comprising an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 2 and which polypeptide binds the C-terminal fragment of GRIP1.

2. The isolated or recombinant polypeptide of claim 1 wherein said peptide substantially lacks methyltransferase activity.

3. The isolated or recombinant polypeptide of claim 1 and wherein a substitution of residues 189, 190, and 191 of SEQ ID NO: 2 results in the substantial lack of methyltransferase activity.

4. The purified or recombinant polypeptide of claim 1 , wherein the polypeptide methylates histone H3.

5. An isolated or recombinant polypeptide comprising the amino acid sequence of SEQ ID NO: 3.

6. An isolated or recombinant polypeptide comprising the amino acid sequence of SEQ ID NO: 2.

7. The isolated or recombinant polypeptide of any one of claim 1 or 6 further comprising a purification domain.

8. The isolated or recombinant polypeptide of claim 7 wherein said purification domain is gluathione-S-transferase.

9. The isolated or recombinant polypeptide of any one of claim 1 or 6 further comprising a DNA binding domain.

10. The isolated or recombinant polypeptide of claim 9 wherein said DNA binding domain is the Gal4 DNA binding domain.

11. The isolated or recombinant polypeptide of any one of claim 1 or 6 further comprising a transcription activation domain.

12. The isolated or recombinant polypeptide of claim 11 wherein said transcription activation domain is the Gal4 transcription activation domain.

13. A solution comprising an isolated or recombinant polypeptide of any one of claim 1 , 3 , 5 , or 6 .

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 22, 2024
From: UNIVERSITY OF SOUTHERN CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH
Reel/Frame 067808/0247 →
CONFIRMATORY LICENSE Recorded May 20, 2009
From: UNIVERSITY OF SOUTHERN CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022707/0104 →
Continuity (4)
Division 10830591 · Apr 22, 2004
Division 09464377 · Dec 15, 1999
Provisional Application 60112523 · Dec 15, 1998
Related Publication 20080051560A1 · Feb 28, 2008